Extended Data Fig. 3: Immunophenotype of KMT2A-rearranged infant B-ALL. | Nature Medicine

Extended Data Fig. 3: Immunophenotype of KMT2A-rearranged infant B-ALL.

From: Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia

Extended Data Fig. 3

Left: Histograms showing surface antigen expression in a representative primary KMT2A-rearranged infant B-ALL sample relative to negative control. Right: Scatterplot showing percentage of cells in each sample expressing ELP-characteristic antigens > negative control (n = 2 xenograft, n = 4 primary KMT2A-rearranged infant B-ALL). Line= mean; 82% CD7+, 93% CD127+ and 82% FLT3+).

Back to article page